CJC-1295 vs Mk 677: Literature and Handling Compared
Researchers comparing CJC-1295 and Mk 677 are usually resolving one question: which compound the published record actually supports for the model in front of them.
Compound profiles
CJC-1295 in the indexed record
The literature on CJC-1295 is a limited body of work: 33 PubMed-indexed records, alongside 1 registered studies on ClinicalTrials.gov.
Recent indexed work appears in Am J Sports Med, Growth Horm IGF Res, J Am Acad Orthop Surg Glob Res Rev, spanning 2006–2026.
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults — J Clin Endocrinol Metab, 2006. PMID: 16352683
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians — Am J Sports Med, 2026. PMID: 41476424
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions — J Am Acad Orthop Surg Glob Res Rev, 2026. PMID: 41490200
- Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions — Subst Use Misuse, 2016. PMID: 26771670
Mk 677 in the indexed record
The literature on Mk 677 is a limited body of work: 41 PubMed-indexed records, alongside 8 registered studies on ClinicalTrials.gov.
Recent indexed work appears in Am J Sports Med, BMJ Case Rep, Exp Physiol, spanning 1998–2026.
- MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism — J Clin Endocrinol Metab, 1998. PMID: 9467534
- Hepatotoxicity induced by MK-677 — BMJ Case Rep, 2025. PMID: 40675653
- LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report — Exp Physiol, 2022. PMID: 36303408
- Peptide Supplements and Their Therapeutic Applications in Sports Medicine — Am J Sports Med, 2026. PMID: 42578445
Side-by-side research profile
| Parameter | CJC-1295 | Mk 677 |
|---|---|---|
| PubMed indexed records | 33 | 41 |
| Registered studies (ClinicalTrials.gov) | 1 | 8 |
| Literature depth | Emerging | Emerging |
| Handling class | Lyophilised powder | Lyophilised powder |
| Designation | Research use only | Research use only |
Classification and why it matters
CJC-1295 and Mk 677 sit in different structural classes, and that classification is what determines whether a published protocol for one has any bearing on the other. Peptide research compounds are grouped by sequence length, origin and the receptor families the literature associates with them — not by the outcome a reader might be looking for.
Reading across classes is the most common error in a literature review. A protocol developed for CJC-1295 describes conditions validated for CJC-1295: concentration ranges, solvent choice, incubation windows and control selection were all established against that compound. Applying those same conditions to Mk 677 without re-validation produces data that cannot be compared back to the source publication.
Where the two compounds are studied in overlapping models, the published work almost always treats them as separate arms rather than as substitutes. That separation is the useful signal: it indicates the research record does not consider them equivalent.
How the literature differs
The indexed record is not symmetrical between these two compounds. Mk 677 carries 8 more indexed records than CJC-1295, which means published methodology, characterisation data and replication attempts are more readily located for Mk 677. For a researcher planning a literature review, that asymmetry usually determines which compound has established reference protocols and which requires primary-source work.
Registered study counts (1 vs 8) track a different signal — formal study registration rather than published output — and the two figures frequently diverge.
Storage and stability
Lyophilised peptide is the stable form. Held sealed at -20°C and shielded from light, it tolerates long storage; once reconstituted that tolerance drops sharply and the working solution is treated as short-lived.
Each freeze-thaw cycle costs integrity, which is why reconstituted material is normally split into single-use aliquots.
Selecting between them for a study design
CJC-1295 and Mk 677 are not interchangeable. They differ in structural class and in the pathways the literature associates with each, so substituting one for the other changes what a model is actually measuring.
Where a protocol cites a specific compound, the cited compound is the one the published result applies to. Where no protocol exists, the compound with the deeper indexed record (Mk 677) generally offers more methodological precedent.
Verification and documentation
What is in the vial is established by lot-specific analytics, not by label text. HPLC gives purity as a share of total peak area; mass spectrometry confirms the molecular weight matches the intended sequence. Neither substitutes for the other.
Frequently asked questions
Which of CJC-1295 or Mk 677 has more published research?
Mk 677, with 41 indexed PubMed records against 33.
Are CJC-1295 and Mk 677 the same compound?
No. They are structurally distinct research compounds with separate literature records — 33 indexed records for CJC-1295 and 41 for Mk 677.
What is the regulatory status of these compounds?
Neither is an approved drug. Both are supplied strictly for in-vitro laboratory research and are not intended for human or veterinary consumption.
Related references
- CJC-1295 — product and lot documentation
- Certificate of analysis & purity testing
- Research reference index
Research use only. The compounds discussed are supplied for in-vitro laboratory research. They are not drugs, are not approved for the diagnosis, treatment, cure or prevention of any condition, and are not intended for human or veterinary consumption.